(Q57158067)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10462235%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

title

An acellular pertussis vaccine in healthy adults: safety and immunogenicity. Pennridge Pediatric Associates (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10462235%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10462235%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

Robert M. Jacobson

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10462235%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

author name string

E P Rothstein

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10462235%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

E L Anderson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10462235%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

G A Poland

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10462235%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

K S Reisinger

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10462235%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

M M Blatter

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10462235%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

C A Mink

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10462235%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

D Gennevois

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10462235%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

A E Izu

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10462235%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

F Sinangil

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10462235%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

A G Langenberg

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10462235%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

language of work or name

English

0 references

publication date

1 August 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10462235%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10462235%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10462235%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

issue

23-24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10462235%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

page(s)

2999-3006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10462235%20AND%20SRC:MED&resulttype=core&format=json

Pertussis and pertussis vaccine. Reanalysis of benefits, risks, and costs

12 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900164-4

7 January 2021

Safety and immunogenicity of Chiron/Biocine recombinant acellular pertussis-diphtheria-tetanus vaccine in infants and toddlers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900164-4

7 January 2021

Acellular pertussis vaccine composed of genetically inactivated pertussis toxin: Safety and immunogenicity in 12- to 24- and 2- to 4-month-old children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900164-4

7 January 2021

Reactogenicity and immunogenicity of a three-component acellular pertussis vaccine administered as the primary series to 2, 4 and 6 month old infants in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900164-4

7 January 2021

A Controlled Trial of Two Acellular Vaccines and One Whole-Cell Vaccine against Pertussis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900164-4

7 January 2021

Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine. Ad Hoc Group for the Study of Pertussis Vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900164-4

7 January 2021

A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900164-4

7 January 2021

Outbreak of pertussis in a fully immunized adolescent and adult population

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900164-4

7 January 2021

A search for Bordetella pertussis infection in university students

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900164-4

7 January 2021

Clinical findings in Bordetella pertussis infections: results of a prospective multicenter surveillance study

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900164-4

7 January 2021

Whooping cough in adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900164-4

7 January 2021

Pertussis Encephalopathy in an Adult: Case Report and Review

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900164-4

7 January 2021

Epidemiological features of pertussis in the United States, 1980-1989.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900164-4

7 January 2021

Pertussis and its prevention: a family affair

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900164-4

7 January 2021

Widespread silent transmission of pertussis in families: antibody correlates of infection and symptomatology

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900164-4

7 January 2021

Intrafamilial spread of pertussis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900164-4

7 January 2021

Acellular pertussis vaccines--a solution to the pertussis problem?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900164-4

7 January 2021

Acellular pertussis vaccines--a solution to the pertussis problem

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900164-4

7 January 2021

Characterization of genetically inactivated pertussis toxin mutants: candidates for a new vaccine against whooping cough

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900164-4

7 January 2021

A search for serologic correlates of immunity to Bordetella pertussis cough illnesses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900164-4

7 January 2021

Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900164-4

7 January 2021

Metabolic, humoral, and cellular responses in adult volunteers immunized with the genetically inactivated pertussis toxin mutant PT-9K/129G.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900164-4

7 January 2021

Development of an acellular pertussis vaccine and its administration as a booster in healthy adults

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900164-4

7 January 2021

Acellular pertussis vaccine in adults: adverse reactions and immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900164-4

7 January 2021

Adult immunization with acellular pertussis vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900164-4

7 January 2021

Use of pertussis vaccine in an epidemic involving hospital staff

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900164-4

7 January 2021

Economic impact of pertussis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900164-4

7 January 2021

The seroepidemiology of Bordetella pertussis infections: a study of persons ages 1-65 years

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900164-4

7 January 2021

Pertussis in German adults

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900164-4

7 January 2021

Management of healthcare workers exposed to pertussis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900164-4

7 January 2021

Antibody responses and persistence in the two years after immunization with two acellular vaccines and one whole-cell vaccine against pertussis.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900164-4

7 January 2021

Acellular pertussis vaccines containing genetically detoxified pertussis toxin induce long-lasting humoral and cellular responses in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900164-4

7 January 2021

10.1016/S0264-410X(99)00164-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10462235%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

1 reference